JP2016508506A5 - - Google Patents

Download PDF

Info

Publication number
JP2016508506A5
JP2016508506A5 JP2015556454A JP2015556454A JP2016508506A5 JP 2016508506 A5 JP2016508506 A5 JP 2016508506A5 JP 2015556454 A JP2015556454 A JP 2015556454A JP 2015556454 A JP2015556454 A JP 2015556454A JP 2016508506 A5 JP2016508506 A5 JP 2016508506A5
Authority
JP
Japan
Prior art keywords
group
alkyl
ring
groups
ring member
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015556454A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016508506A (ja
JP6314335B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/051878 external-priority patent/WO2014122067A1/en
Publication of JP2016508506A publication Critical patent/JP2016508506A/ja
Publication of JP2016508506A5 publication Critical patent/JP2016508506A5/ja
Application granted granted Critical
Publication of JP6314335B2 publication Critical patent/JP6314335B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015556454A 2013-02-06 2014-01-31 新しいインダニルオキシジヒドロベンゾフラニル酢酸 Expired - Fee Related JP6314335B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13154261 2013-02-06
EP13154261.5 2013-02-06
PCT/EP2014/051878 WO2014122067A1 (en) 2013-02-06 2014-01-31 New indanyloxydihydrobenzofuranylacetic acids

Publications (3)

Publication Number Publication Date
JP2016508506A JP2016508506A (ja) 2016-03-22
JP2016508506A5 true JP2016508506A5 (cg-RX-API-DMAC7.html) 2017-03-09
JP6314335B2 JP6314335B2 (ja) 2018-04-25

Family

ID=47681765

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015556454A Expired - Fee Related JP6314335B2 (ja) 2013-02-06 2014-01-31 新しいインダニルオキシジヒドロベンゾフラニル酢酸

Country Status (7)

Country Link
US (1) US8927531B2 (cg-RX-API-DMAC7.html)
EP (1) EP2953681B1 (cg-RX-API-DMAC7.html)
JP (1) JP6314335B2 (cg-RX-API-DMAC7.html)
AR (1) AR095163A1 (cg-RX-API-DMAC7.html)
TW (1) TW201518284A (cg-RX-API-DMAC7.html)
UY (1) UY35312A (cg-RX-API-DMAC7.html)
WO (1) WO2014122067A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6352415B2 (ja) 2013-11-14 2018-07-04 カディラ・ヘルスケア・リミテッド 新規なヘテロ環化合物
CN105566263A (zh) * 2016-01-27 2016-05-11 中国药科大学 一类新型含氮杂环衍生物、其制备方法及其作为药物的用途
JOP20190060A1 (ar) 2016-09-26 2019-03-26 Chugai Pharmaceutical Co Ltd مشتق بيرازولو بيريدين له تأثير مساعد لمستقبل glp-1
JP7461104B2 (ja) * 2017-11-29 2024-04-03 中外製薬株式会社 Glp-1受容体アゴニスト作用を持つピラゾロピリジン誘導体を含有する医薬組成物
CN118084940A (zh) 2018-02-13 2024-05-28 吉利德科学公司 Pd-1/pd-l1抑制剂
AU2019255750B2 (en) 2018-04-19 2021-10-21 Gilead Sciences, Inc. PD-1/PD-L1 inhibitors
PE20210642A1 (es) 2018-07-13 2021-03-23 Gilead Sciences Inc Inhibidores de pd-1/pd-l1
CN112955435B (zh) 2018-10-24 2024-09-06 吉利德科学公司 Pd-1/pd-l1抑制剂
IL291985A (en) 2019-10-07 2022-06-01 Kallyope Inc Gpr119 agonists
PH12022552056A1 (en) * 2020-02-07 2024-02-12 Gasherbrum Bio Inc Heterocyclic glp-1 agonists
PH12022552277A1 (en) 2020-02-28 2024-03-04 Kallyope Inc Gpr40 agonists
UY39222A (es) 2020-05-19 2021-11-30 Kallyope Inc Activadores de la ampk
EP4172162A4 (en) 2020-06-26 2024-08-07 Kallyope, Inc. AMPK ACTIVATORS
EP4665730A1 (en) 2023-02-16 2025-12-24 Gasherbrum Bio, Inc. Heterocyclic glp-1 agonists

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4594611B2 (ja) * 2002-11-08 2010-12-08 武田薬品工業株式会社 受容体機能調節剤
AU2003277576A1 (en) 2002-11-08 2004-06-07 Takeda Pharmaceutical Company Limited Receptor function controlling agent
JP4805552B2 (ja) * 2003-05-30 2011-11-02 武田薬品工業株式会社 縮合環化合物
EP1924546A1 (en) 2005-09-14 2008-05-28 Amgen, Inc Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
JP2009530281A (ja) * 2006-03-14 2009-08-27 アムジエン・インコーポレーテツド 代謝障害の治療に有用である二環式カルボン酸誘導体
DK2041123T3 (da) 2006-06-27 2012-05-07 Takeda Pharmaceutical Kondenserede cykliske forbindelser.
NZ588983A (en) 2008-06-25 2011-11-25 Daiichi Sankyo Co Ltd Carboxylic acid compound
JP5657578B2 (ja) * 2009-06-09 2015-01-21 武田薬品工業株式会社 新規な縮合環化合物およびその用途
WO2012072691A1 (en) 2010-12-01 2012-06-07 Boehringer Ingelheim International Gmbh Indanyloxydihydrobenzofuranylacetic acids
US8809376B2 (en) * 2012-04-30 2014-08-19 Boehringer Ingelheim International Gmbh Indanyloxydihydrobenzofuranylacetic acids

Similar Documents

Publication Publication Date Title
JP2016508506A5 (cg-RX-API-DMAC7.html)
JP2018535963A5 (cg-RX-API-DMAC7.html)
JP2011523412A5 (cg-RX-API-DMAC7.html)
ECSP22008098A (es) Compuestos agonistas de gipr
JP2014511892A5 (cg-RX-API-DMAC7.html)
JP2014511891A5 (cg-RX-API-DMAC7.html)
JP2013519675A5 (cg-RX-API-DMAC7.html)
MX2015001500A (es) Compuestos antidiabeticos triciclicos.
JP2019524883A5 (cg-RX-API-DMAC7.html)
JP2018536648A5 (cg-RX-API-DMAC7.html)
JP2007538024A5 (cg-RX-API-DMAC7.html)
JP2017523226A5 (cg-RX-API-DMAC7.html)
JP2010523476A5 (cg-RX-API-DMAC7.html)
JP2016503797A5 (cg-RX-API-DMAC7.html)
CL2021000528A1 (es) Compuestos de 2,6-diaminopiridina
JP2016510326A5 (cg-RX-API-DMAC7.html)
RU2015147447A (ru) Производные доластатина 10 и ауристатинов
JP2020517619A5 (cg-RX-API-DMAC7.html)
JP2015516427A5 (cg-RX-API-DMAC7.html)
JP2019516739A5 (cg-RX-API-DMAC7.html)
JP2015521195A5 (cg-RX-API-DMAC7.html)
JP2019520344A5 (cg-RX-API-DMAC7.html)
JP2017503760A5 (cg-RX-API-DMAC7.html)
JP2016527223A5 (cg-RX-API-DMAC7.html)
JP2016528273A5 (cg-RX-API-DMAC7.html)